The discovery of novel sanjuanolide derivatives as chemotherapeutic agents targeting castration-resistant prostate cancer.
The discovery of novel sanjuanolide derivatives as chemotherapeutic agents targeting castration-resistant prostate cancer.
复制标题
发现新型三胡内酯衍生物作为针对去势抵抗性前列腺癌的化疗药物。
DOI:
10.1016/j.bioorg.2021.104880
复制
发表时间:
2021-03
影响因子:
5.1
通讯作者:
Zheng Xiaohui
中科院分区:
文献类型:
--
作者:
Wang Guangbao;Chen Xiaojing;Wang Nan;Xiao Yunbei;Shu Sheng;Alsayed Ali Mohammed Mohammed;Liu Lu;Ma Yue;Liu Peng;Zhang Qianwen;Chen Xiangjuan;Liu Zhiguo;Zheng Xiaohui
There remains a critical need for more effective therapies for the treatment of castration-resistant prostate cancer (CRPC), which is the leading cause of death in patients with prostate cancer. In this study, a series of sanjuanolide derivatives were designed, synthesized and evaluated as potential anti-CRPC agents. Most of the compounds had excellent selectivity for CRPC cells withIC50values < 20 µM. Moreover, minimal side effects on human normal hepatic MIHA cells and normal prostatic stromal myofibroblast WPMY-1 cells were observed, withIC50> 100 µM. The representative compoundS07slowed down the proliferative rate of CRPC cells, promoted cell apoptosis and caused G2/M phase accumulation, as well as G1/G0 phase reduction. Further mechanistic studies showed that S07treatment triggered intense DNA damage and provoked strong DNA damage response in a dose-dependent manner. These findings suggested that sanjuanolide derivatives, especiallyS07,selectively induced CRPC cell death by triggering intense DNA damage and DNA damage response.
登录
查看更多内容
影响因子:
4
作者:
Xiao-Hui Zheng;Y. Zhong;Cai-Ping Tan;L. Ji;Z. Mao
通讯作者:
Xiao-Hui Zheng;Y. Zhong;Cai-Ping Tan;L. Ji;Z. Mao
影响因子:
14.8
作者:
Olive, Peggy L.;Banath, Judit P.
通讯作者:
Banath, Judit P.
影响因子:
4.8
作者:
Boulares, AH;Yakovlev, AG;Smulson, M
通讯作者:
Smulson, M
影响因子:
5.1
作者:
Shaffer CV;Cai S;Peng J;Robles AJ;Hartley RM;Powell DR;Du L;Cichewicz RH;Mooberry SL
通讯作者:
Mooberry SL
影响因子:
2.6
作者:
S. Hotte;F. Saad
通讯作者:
S. Hotte;F. Saad